This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Neuronetics appoints Robert Greene SVP Sales
Business executive appointment

Neuronetics appoints Robert Greene SVP Sales

Analysis based on 6 articles · First reported Jun 02, 2026 · Last updated Jun 02, 2026

Sentiment
20
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The appointment of Robert Greenberg as Senior Vice President Sales for Neuronetics is a positive development, as his experience is expected to enhance the company's commercial strategy and sales. This could lead to improved sales performance and potentially a positive impact on Neuronetics' stock price.

medical technology healthcare
Event Summary

Neuronetics, Inc., a medical technology company, announced the appointment of Robert Greenberg as its Senior Vice President Sales, effective June 1, 2026. Mr. Greene brings extensive experience in commercial strategy and sales within the healthcare and medical technology sectors. In connection with his hiring, Neuronetics' Compensation Committee authorized an inducement grant to Mr. Greene of restricted stock units representing 200,000 shares of the company's common stock, which will vest in four equal annual installments. Neuronetics is known for its NeuroStar Advanced Therapy and operates Greenbrook TMS treatment centers.

Entities Involved
stock
Neuronetics
Neuronetics appointed Robert Greenberg as Senior Vice President Sales, which is expected to strengthen its commercial strategy and sales organizations. The company also granted him restricted stock units as an inducement.
Importance 100.0 Sentiment 20.0
per
Robert Greenberg
Robert Greenberg was appointed as Senior Vice President Sales for Neuronetics, bringing extensive experience in healthcare and medical technology sales. He received an inducement grant of restricted stock units.
Importance 90.0 Sentiment 20.0
stock
Greenbrook TMS
Greenbrook TMS is operated by Neuronetics and offers NeuroStar Advanced Therapy and SPRAVATO treatment centers across the United States.
Importance 20.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
The United States — Food and Drug Administration has cleared the NeuroStar Advanced Therapy System for various neurohealth conditions, providing regulatory approval for Neuronetics' key product.
Importance 10.0 Sentiment 0.0
index
Nasdaq-100
Nasdaq-100 is the stock exchange where Neuronetics is listed, and its listing rules govern the inducement grant to Robert Greenberg.
Importance 10.0 Sentiment 0.0
Relationships
United States — Food and Drug Administration related ↔ Nasdaq-100
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.